Published in Clin Infect Dis on May 26, 2004
Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence (2011) 2.14
Prosthetic joint infection. Clin Microbiol Rev (2014) 1.97
Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2014) 1.56
Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol (2015) 1.47
General principles of antimicrobial therapy. Mayo Clin Proc (2011) 1.42
Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug Users. Open Forum Infect Dis (2017) 1.07
Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis (2013) 1.06
A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus. Clin Infect Dis (2011) 1.06
Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother (2009) 1.05
Ruptured mycotic aneurysm of the distal middle cerebral artery manifesting as subacute subdural hematoma. J Cerebrovasc Endovasc Neurosurg (2013) 1.05
Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis (2014) 1.02
A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection. Clin Infect Dis (2015) 0.95
Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability. PLoS One (2014) 0.94
Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy. Clin Infect Dis (2015) 0.94
Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting. Eur J Clin Microbiol Infect Dis (2009) 0.93
Outpatient parenteral antimicrobial therapy. Can J Infect Dis Med Microbiol (2013) 0.92
Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis (2008) 0.91
Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations. Antimicrob Agents Chemother (2008) 0.91
Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence. Clin Infect Dis (2013) 0.89
Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry. Int J Clin Pract (2008) 0.88
Continuous clindamycin infusion, an innovative approach to treating bone and joint infections. Antimicrob Agents Chemother (2009) 0.88
Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin. Clinicoecon Outcomes Res (2013) 0.87
Neutropenia Associated with Long-Term Ceftaroline Use. Antimicrob Agents Chemother (2015) 0.85
Changes in antimicrobial use prevalence in China: results from five point prevalence studies. PLoS One (2013) 0.84
Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections. Mayo Clin Proc (2012) 0.83
Chemical Stability of Telavancin in Elastomeric Pumps. Curr Ther Res Clin Exp (2015) 0.83
Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches. J Antimicrob Chemother (2015) 0.82
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2006) 0.82
About the guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis (2004) 0.82
Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity. Eur J Clin Microbiol Infect Dis (2016) 0.82
Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe. BMC Infect Dis (2014) 0.81
Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians. Infect Control Hosp Epidemiol (2014) 0.81
Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. J Allergy Clin Immunol (2015) 0.80
Tolerability of cefazolin after immune-mediated hypersensitivity reactions to nafcillin in the outpatient setting. Antimicrob Agents Chemother (2014) 0.80
Home intravenous therapy: Accessibility for Canadian children and youth. Paediatr Child Health (2011) 0.80
Managing an outpatient parenteral antibiotic therapy team: challenges and solutions. Ther Clin Risk Manag (2014) 0.79
Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study. Can J Infect Dis Med Microbiol (2016) 0.78
The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy. J Pharm Technol (2013) 0.78
Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates. Infect Drug Resist (2015) 0.77
Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients. Front Neurol (2014) 0.77
Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island. R I Med J (2013) (2014) 0.75
Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care. Can J Infect Dis Med Microbiol (2013) 0.75
Native valve endocarditis caused by coagulase negative staphylococci; an appeal to start outpatient antimicrobial therapy: an unusual case report. Oman Med J (2011) 0.75
Vancomycin and home health care. Emerg Infect Dis (2005) 0.75
Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey. Eur J Clin Microbiol Infect Dis (2013) 0.75
Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services. BMJ Open (2015) 0.75
Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia. Ann Saudi Med (2011) 0.75
Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program. Open Forum Infect Dis (2016) 0.75
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections. Infect Drug Resist (2016) 0.75
Primary Cytomegalovirus-Related Eosinophilic Pneumonia in a Three-year-old Child with Acute Lymphoblastic Leukaemia: Case report and literature review. Sultan Qaboos Univ Med J (2014) 0.75
Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis. BMC Infect Dis (2015) 0.75
Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study. PLoS Med (2015) 0.75
Managing infective endocarditis in the elderly: new issues for an old disease. Clin Interv Aging (2016) 0.75
Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network. Open Forum Infect Dis (2017) 0.75
Adverse Events in Pediatric Patients Receiving Long-Term Outpatient Antimicrobials. J Pediatric Infect Dis Soc (2014) 0.75
Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications. BMC Infect Dis (2017) 0.75
Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study. BMC Infect Dis (2014) 0.75
Endocarditis in the 21(st) Century. Maedica (Buchar) (2011) 0.75
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections. Eur J Clin Microbiol Infect Dis (2015) 0.75
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections. Infect Dis Ther (2017) 0.75
Patient satisfaction in an outpatient parenteral antimicrobial therapy (OPAT) unit practising predominantly self-administration of antibiotics with elastomeric pumps. Eur J Clin Microbiol Infect Dis (2017) 0.75
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm (2009) 7.43
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis (2011) 5.58
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis (2009) 5.52
Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol (2011) 3.81
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics (2004) 3.71
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. Clin Infect Dis (2008) 2.73
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis (2009) 2.54
Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clin Infect Dis (2012) 2.47
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2005) 2.28
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
The value of an infectious diseases specialist. Clin Infect Dis (2003) 2.12
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2013) 1.90
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis (2009) 1.83
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics (2010) 1.77
Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J (2007) 1.65
Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus. South Med J (2005) 1.64
Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest (2005) 1.57
Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy (2009) 1.55
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis (2006) 1.54
Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J (2013) 1.52
Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J (2004) 1.52
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis (2012) 1.49
Best in class: a good principle for antibiotic usage to limit resistance development? J Antimicrob Chemother (2007) 1.44
Management of complicated shunt infections: a clinical report. J Neurosurg Pediatr (2008) 1.42
Decreased mortality associated with prompt Gram staining of blood cultures. Am J Clin Pathol (2008) 1.42
Staghorn calculus endotoxin expression in sepsis. Urology (2002) 1.41
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J (2007) 1.41
What is the appropriate treatment course for bacterial arthritis in children? Clin Infect Dis (2009) 1.39
Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol (2010) 1.36
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J (2002) 1.28
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. J Antimicrob Chemother (2005) 1.26
The use of systemic and topical fluoroquinolones. Pediatrics (2011) 1.25
Evaluation of acoustical conditions for speech communication in working elementary school classrooms. J Acoust Soc Am (2008) 1.22
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg (2010) 1.22
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (2014) 1.17
Streptococcus pneumoniae infections in the neonate. Pediatrics (2003) 1.14
Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Antimicrob Agents Chemother (2010) 1.11
Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis (2008) 1.11
Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J (2002) 1.09
Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002. Ann Clin Microbiol Antimicrob (2004) 1.07
The value of infectious diseases specialists: non-patient care activities. Clin Infect Dis (2008) 1.06
Human west nile virus neuroinvasive disease in Texas, 2003 epidemic: regional differences. Ann Epidemiol (2006) 1.05
Early detection of central nervous system tuberculosis with the gen-probe nucleic Acid amplification assay: utility in an inner city hospital. Clin Infect Dis (2002) 1.05
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J (2010) 1.04
Salvage treatment of histoplasmosis with posaconazole. J Infect (2006) 1.04
Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis (2006) 1.02
Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis (2002) 1.00
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother (2006) 1.00
Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents (2003) 0.98
Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. J Hosp Med (2012) 0.98
Defining pneumonia in critically ill infants and children. Pediatr Crit Care Med (2005) 0.97
Quality of care among Aboriginal hemodialysis patients. Clin J Am Soc Nephrol (2005) 0.96
Extrapulmonary Tuberculosis among Somalis in Minnesota. Emerg Infect Dis (2006) 0.95
Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol (2011) 0.95
Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections. Pediatr Infect Dis J (2011) 0.93
Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin (2007) 0.93
The association of septic thrombophlebitis with septic pulmonary embolism in adults. Open Respir Med J (2012) 0.93
Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. Am J Trop Med Hyg (2007) 0.92
Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis (2010) 0.91
Levofloxacin pharmacokinetics in children. J Clin Pharmacol (2005) 0.91
ATS, CDC, and IDSA update recommendations on the treatment of tuberculosis. Am Fam Physician (2003) 0.91
Initial management of acute bacterial meningitis in adults: summary of IDSA guidelines. Rev Neurol Dis (2006) 0.90
Deep sternal wire infection resulting in severe pulmonary valve endocarditis. Ann Thorac Surg (2006) 0.90
Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature. Arch Pathol Lab Med (2012) 0.90
Endotoxin content in renal calculi. J Urol (2003) 0.89
Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists. Diagn Microbiol Infect Dis (2013) 0.89
Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study. J Antimicrob Chemother (2014) 0.88
Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300. BMC Genomics (2012) 0.87
Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review. Clin Infect Dis (2002) 0.87
Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. J Antimicrob Chemother (2013) 0.87
Health-system pharmacists' role in improving immunization rates. Am J Health Syst Pharm (2012) 0.87
Pneumococcal endocarditis in children. Clin Infect Dis (2004) 0.86
Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol (2013) 0.86
In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother (2003) 0.85
Vancomycin monitoring in children using bayesian estimation. Ther Drug Monit (2014) 0.84
Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy. Clin Infect Dis (2010) 0.84
Pharmacokinetics of gatifloxacin in infants and children. Antimicrob Agents Chemother (2005) 0.83
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents. Antimicrob Agents Chemother (2007) 0.83
An artificial neural network approach for predicting architectural speech security. J Acoust Soc Am (2005) 0.82
Measures for assessing architectural speech security (privacy) of closed offices and meeting rooms. J Acoust Soc Am (2004) 0.81
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam. J Antimicrob Chemother (2004) 0.81
Prediction of neurologic sequelae in childhood tuberculous meningitis: a review of 20 cases and proposal of a novel scoring system. Pediatr Infect Dis J (2005) 0.81
Vancomycin: a 50-something-year-old antibiotic we still don't understand. Cleve Clin J Med (2011) 0.81
Pediatric anthrax clinical management. Pediatrics (2014) 0.81
Linezolid-associated peripheral and optic neuropathy in children. Pediatrics (2011) 0.81
Infections in hospitalized patients: what is happening and who can help? Cleve Clin J Med (2007) 0.80
Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis (2004) 0.80
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J (2016) 0.79
Hot-tub-associated mycobacterial infections in immunosuppressed persons. Emerg Infect Dis (2002) 0.79
Exchange blood transfusion in the management of severe pertussis in young infants. Pediatr Infect Dis J (2013) 0.79
Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic. Clin Infect Dis (2008) 0.78